中國人壽(02628.HK)委任黃秀美為公司副總裁及財務負責人
格隆匯4月23日丨中國人壽(02628.HK)公佈,董事會於2020年4月23日收到趙鵬的辭任函。因工作變動,趙鵬向董事會提出辭任公司執行董事、戰略與資產負債管理委員會委員及財務負責人職務,該辭任於同日起生效。
董事會進一步宣佈,於2020年4月23日舉行的第六屆董事會第二十五次會議上,黃秀美獲委任為公司副總裁及財務負責人。黃秀美的任職資格尚待中國銀保監會核准,在取得中國銀保監會核准前,公司指定黃秀美為臨時財務負責人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.